Moreover, in seeking an effective targeted‐therapy for PAAD patients’ management, our study later identified a small molecule, berberine, which functionally inhibits LDHA and suppresses in vitro and in vivo PAAD progression. This evidence concerns the gene LDHA and pancreatic adenocarcinoma.